LIMN
Liminatus Pharma, Inc. Class A Common Stock NASDAQ Listed May 1, 2025$3.91
-8.43%
vs $4.27
Mkt Cap $92.9M
52w Low $0.10
54.7% of range
52w High $7.07
50d MA $2.80
200d MA $0.98
P/E (TTM)
-0.2x
EV/EBITDA
—
P/B
—
Debt/Equity
-0.1x
ROE
104.0%
P/FCF
-9.3x
RSI (14)
61.10
ATR (14)
$0.28
Beta
0.63
50d MA
$2.80
200d MA
$0.98
Avg Volume
41.8K
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
CIK (SEC)
Phone
213 273 5453
6 Centerpointe Drive · La Palma, CA 90623 · US
Data updated apr 25, 2026 7:13pm
· Source: financialmodelingprep.com